中文名稱：聚乙丙交酯(65/35)、丙交酯乙交酯共聚物、聚(D,L-乳酸- co-乙醇酸)

英文名稱：PLGA(65/35)、poly(D,L-lactic acid-co-glycolic acid)、Poly(D,L-lactide-co-glycolide)

聚（D，L-丙交酯-共-乙交酯）是一種(zhǒng)可生物降解的生物相容性聚合物，可用于藥物輸送。它可用于治療類風濕性關節炎、潰瘍性結腸炎、克羅恩病、炎性肺病、以及眼部炎性疾病。聚（D，L-丙交酯-共-乙交酯）可作爲潛在的癌症治療靶标起(qǐ)作用。
聚（D，L-丙交酯-共-乙交酯）已經(jīng)用于在凝膠中提高和維持乳酸鹽單體水平，其濃度與皮膚傷口有關。
特點和優勢在于控釋生物活性劑、縫線和可生物吸收植入器件，具有生物相容性且可生物降解的聚合物。

Poly (D, L-lactide co glycolide) is a biodegradable biocompatible polymer, which can be used for drug delivery. It can be used to treat rheumatoid arthritis, ulcerative colitis, Crohn's disease, inflammatory lung disease, and ocular inflammatory diseases. Poly (D, L-lactide co glycolide) can act as a potential cancer therapeutic target.

Poly (D, L- lactide co glycolide) has been used to improve and maintain lactate monomer level in gel, and its concentration is related to skin wound.

The characteristics and advantages are controlled-release bioactive agents, sutures and bioabsorbable implant devices, biocompatible and biodegradable polymers.